EIF2A: Key Protein in Eukaryotic Protein Synthesis and Cytoskeleton Regulation

Target Name: EIF2A

NCBI ID: G83939

EIF2A

EIF2A: Key Protein in Eukaryotic Protein Synthesis and Cytoskeleton Regulation

EIF2A, also known asukaryotic translation initiation factor 2A, is a protein that plays a crucial role in the process of protein synthesis in eukaryotic cells. It is a key factor in the initiation of the translation of mRNAs, which are the templates for protein synthesis. EIF2A is a protein that is expressed in most eukaryotic cells and is involved in the process of translation of mRNAs from the nucleus to the cytoplasm.

One of the functions of EIF2A is to interact with the small nuclear RNA (snRNA) scaffold, which is a protein that helps to recruit other proteins to the nuclear envelope. This interaction between EIF2A and scaffold allows for the recruitment of other proteins to the nuclear envelope, where they can help to process and translocate mRNAs to the cytoplasm.

EIF2A is also involved in the regulation of the cytoskeleton. It helps to control the distribution of the cytoskeleton in the cytoplasm and helps to maintain the integrity of the cytoskeleton. This is important for the proper functioning of the cell and is implicated in a number of diseases, including cancer.

In addition to its role in the regulation of the cytoskeleton, EIF2A is also involved in the process of protein synthesis. It is a key factor in the initiation of the translation of mRNAs and helps to ensure that the correct sequence of amino acids is added to the protein. This is important for the production of properly functioning proteins, which are essential for the proper functioning of the cell.

EIF2A is also a potential drug target. Its role in the regulation of the cytoskeleton and its involvement in the process of protein synthesis make it an attractive target for drug development. Additionally, because EIF2A is involved in the regulation of the cytoskeleton, it is possible that drugs that inhibit its activity may have therapeutic benefits in a variety of diseases, including cancer.

Overall, EIF2A is a protein that plays a crucial role in the process of protein synthesis and cytoskeleton regulation in eukaryotic cells. Its role in these processes makes it an attractive target for drug development, and its involvement in the regulation of the cytoskeleton makes it a potential therapeutic target in a variety of diseases. Further research is needed to fully understand the role of EIF2A in these processes and to develop effective treatments.

Protein Name: Eukaryotic Translation Initiation Factor 2A

Functions: Functions in the early steps of protein synthesis of a small number of specific mRNAs. Acts by directing the binding of methionyl-tRNAi to 40S ribosomal subunits. In contrast to the eIF-2 complex, it binds methionyl-tRNAi to 40S subunits in a codon-dependent manner, whereas the eIF-2 complex binds methionyl-tRNAi to 40S subunits in a GTP-dependent manner

The "EIF2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets